DE60201839D1 - Verfahren zur arzneimittelaktivierung in einer schwingmühle - Google Patents

Verfahren zur arzneimittelaktivierung in einer schwingmühle

Info

Publication number
DE60201839D1
DE60201839D1 DE60201839T DE60201839T DE60201839D1 DE 60201839 D1 DE60201839 D1 DE 60201839D1 DE 60201839 T DE60201839 T DE 60201839T DE 60201839 T DE60201839 T DE 60201839T DE 60201839 D1 DE60201839 D1 DE 60201839D1
Authority
DE
Germany
Prior art keywords
drug
medicinal products
mill
vibrating mill
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60201839T
Other languages
English (en)
Other versions
DE60201839T2 (de
Inventor
Luca Dobetti
Massimo Bresciani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Pharmaceuticals Holdings Ireland ULC
Original Assignee
Eurand Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Pharmaceuticals Ltd filed Critical Eurand Pharmaceuticals Ltd
Publication of DE60201839D1 publication Critical patent/DE60201839D1/de
Application granted granted Critical
Publication of DE60201839T2 publication Critical patent/DE60201839T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
    • B02C17/18—Details
    • B02C17/20—Disintegrating members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
    • B02C17/14—Mills in which the charge to be ground is turned over by movements of the container other than by rotating, e.g. by swinging, vibrating, tilting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Crushing And Grinding (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60201839T 2001-06-29 2002-06-27 Verfahren zur arzneimittelaktivierung in einer schwingmühle Expired - Lifetime DE60201839T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE20010626 2001-06-29
IE20010626 2001-06-29
PCT/EP2002/007117 WO2003002259A1 (en) 2001-06-29 2002-06-27 Process for activation of drugs in a vibrational mill

Publications (2)

Publication Number Publication Date
DE60201839D1 true DE60201839D1 (de) 2004-12-09
DE60201839T2 DE60201839T2 (de) 2005-10-27

Family

ID=11042809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60201839T Expired - Lifetime DE60201839T2 (de) 2001-06-29 2002-06-27 Verfahren zur arzneimittelaktivierung in einer schwingmühle

Country Status (9)

Country Link
US (1) US7951399B2 (de)
EP (1) EP1406728B1 (de)
JP (1) JP4191597B2 (de)
AT (1) ATE281241T1 (de)
AU (1) AU2002321130B2 (de)
CA (1) CA2450907C (de)
DE (1) DE60201839T2 (de)
NZ (1) NZ530827A (de)
WO (1) WO2003002259A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1713893A (zh) * 2002-11-18 2005-12-28 纳幕尔杜邦公司 采用非球形研磨介质的介质研磨
JP4065902B2 (ja) * 2006-04-28 2008-03-26 ライオン株式会社 造粒粒子、錠剤、及び造粒粒子の製造方法
EP2174717B1 (de) 2008-10-09 2020-04-29 Imertech Sas Schleifverfahren
WO2015071841A1 (en) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
CN105268518B (zh) * 2014-05-29 2020-04-14 河北首鼎金属材料股份有限公司 多功能多棱磨球

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60137453A (ja) * 1983-12-26 1985-07-22 東芝セラミツクス株式会社 ミル用エレメント
US4932166A (en) * 1986-05-30 1990-06-12 The Carborundum Company Inert autogenous attrition grinding
DE4413849A1 (de) * 1994-04-21 1995-10-26 Hoechst Ag Feinverteilungsverfahren zur Herstellung von organischen Pigmenten
ES2149471T3 (es) * 1995-04-20 2000-11-01 Eurand Int Compuesto con glicolato de almidon sodico como material soporte y productos a base de dicho compuesto.
JP2000103658A (ja) * 1998-09-30 2000-04-11 Mitsubishi Materials Corp 骨材の回収方法およびその装置

Also Published As

Publication number Publication date
CA2450907C (en) 2011-08-23
ATE281241T1 (de) 2004-11-15
US7951399B2 (en) 2011-05-31
DE60201839T2 (de) 2005-10-27
JP4191597B2 (ja) 2008-12-03
CA2450907A1 (en) 2003-01-09
JP2004530558A (ja) 2004-10-07
US20040170682A1 (en) 2004-09-02
NZ530827A (en) 2005-06-24
EP1406728B1 (de) 2004-11-03
AU2002321130B2 (en) 2006-11-09
WO2003002259A1 (en) 2003-01-09
EP1406728A1 (de) 2004-04-14

Similar Documents

Publication Publication Date Title
HUP0204337A2 (hu) Biciklusos vegyületek androgén- és progeszteron-receptor modulátor hatással és ezeket tartalmazó gyógyszerkészítmények
TWI315203B (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
AP1818A (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
HUP0303391A3 (en) Aliphatic nitrogenous five-membered ring compounds, process for their preparation, pharmaceutical compositions containing them and their use
NL300267I1 (nl) Werkwijze voor het bereiden van met gas gevulde lipide-microbollen en met gas gevulde lipide-microbollen.
HUP0004050A2 (hu) Javított oldódású itrakonazol, eljárás ennek előállítására és ezt tartalmazó orális gyógyszerkészítmény
GB0013488D0 (en) Chemical compound
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
SE0300480D0 (sv) Novel compounds
FR2795646B1 (fr) Article manufacture pour un usage pharmaceutique humain
NZ332233A (en) Denaturants for sympathomimetic amine salts to make these compounds less suitable as starting materials for the production of illegal drugs
GB0109122D0 (en) Novel compounds
DE60201839D1 (de) Verfahren zur arzneimittelaktivierung in einer schwingmühle
DE60205491D1 (de) Verfahren zur arzneimittelaktivierung mittels schwingmühle
HUP0300334A2 (hu) Gyógyászati készítmények és eljárások azok elżállítására
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
HUP0202233A3 (en) Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
DE69527711T2 (de) Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt
PL352476A1 (en) Novel derivatives of piperazinylalkylthiopyrimidine, parmacological compositions containing tese compounds and method of obtaining active substance
MXPA04005552A (es) Analogos de vitamina d.
WO2004046096A3 (en) Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics
MXPA05006528A (es) Proceso para preparar formulaciones farmaceuticas en combinacion utilizando fluidos supercriticos.
ATE347886T1 (de) Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
JPS5225015A (en) Process for preparing fine granular drugs
AU2003300018A8 (en) Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition